Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-26T07:15:12.993Z Has data issue: false hasContentIssue false
  • English
  • Français

Confirmation of Nosocomial Hepatitis C Virus Infection in a Hemodialysis Unit

Published online by Cambridge University Press:  02 January 2015

Norihiro Furusyo ,
Norihiko Kubo ,
Hisashi Nakashima ,
Kenichiro Kashiwagi ,
Yoshitaka Etoh  and
Jun Hayashi
Norihiro Furusyo*
Affiliation:
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan Department of Environmental Medicine and Infectious Disease, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
Norihiko Kubo
Affiliation:
Department of Environmental Medicine and Infectious Disease, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
Hisashi Nakashima
Affiliation:
Department of Environmental Medicine and Infectious Disease, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
Kenichiro Kashiwagi
Affiliation:
Department of Environmental Medicine and Infectious Disease, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
Yoshitaka Etoh
Affiliation:
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
Jun Hayashi
Affiliation:
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan Department of Environmental Medicine and Infectious Disease, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
*
Department of General Medicine, Kyushu University Hospital, Higashi-Ku, Fukuoka, 812-8582, Japan
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

To investigate a hepatitis C virus (HCV) outbreak in a hemodialysis unit and determine the source of transmission.

Methods:

We have prospectively investigated the epidemiology of hemodialysis-related HCV infection in a single unit since 1989. In September 2000, acute hepatitis C (AH-C) was diagnosed in 5 patients by alanine aminotransferase elevation and HCV genotype lb viremia without antibody to HCV. We surveyed the epidemiologic situation and performed polymerase chain reaction sequence analysis of the HCV 5'-noncoding (5'NC) region in the patients for comparison with 9 patients with chronic HCV genotype 1b viremia.

Results:

Sequence analysis of the 5'NC region showed the consistency in the 5 independent clones from each AH-C patient and those from each chronic HCV viremia patient and no quasispecies over time in the clones of any of 14 analyzed patients. All AH-C patients had the same sequencing of the 6 variations in the region with the only other patient. A saline ampoule, used for heparin solution during hemodialysis, had a recap function. It was difficult to determine whether the ampoule was new or had already been used. The source-patient often underwent hemodialysis before the AH-C patients and most of their hemodialysis-related medicine was prepared during the source-patient's treatment. These findings suggested a high possibility that the AH-C patients shared a single heparin–saline solution ampoule contaminated by HCV from the source-patient.

Conclusion:

Nosocomial HCV infection occurred as a result of poor infection control practice when a patient with chronic HCV viremia received treatment prior to other hemodialysis patients.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 25 , Issue 7 , July 2004 , pp. 584 - 590
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Hayashi, J, Nakashima, K, Yoshimura, E, et al.Prevalence and role of hepatitis C viraemia in haemodialysis patients in Japan. J Infect 1994;28:271–277.Google Scholar
2.van der Poel, CL, Cuypers, HT, Reesink, HW. Hepatitis C virus six years on. Lancet 1994;344:1475–1479.Google Scholar
3.Hayashi, J, Nakashima, K, Kajiyama, W, et al.Prevalence of antibody to hepatitis C virus in hemodialysis patients. Am J Epidemiol 1991;134:651–657.Google Scholar
4.Hayashi, J, Kishihara, Y, Yamaji, K, et al.Transmission of hepatitis C virus by health care workers in a rural area of Japan. Am J Gastroenterol 1995;90:794–799.Google Scholar
5.Sakamoto, N, Enomoto, N, Marumo, F, Sato, C. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma. J Med Virol 1993;39:11–15.Google Scholar
6.Alter, HJ, Purcell, RH, Shih, JW, et al.Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494–1500.Google Scholar
7.Ifudu, O, Macey, LJ, Friedman, EA. Resurgence of blood transfusion therapy in erythropoietin treated hemodialysis patients. ASAIO J 1995;41:426–430.Google Scholar
8.Eschbach, JW, Egrie, JC, Downing, MR, et al.Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a combined phase I and II clinical trial. N Engl J Med 1987;316:73–78.CrossRefGoogle ScholarPubMed
9.Furusyo, N, Hayashi, J, Kakuda, K, et al.Acute hepatitis C among Japanese hemodialysis patients: a prospective 9-year study. Am J Gastroenterol 2001;96:1592–1600.Google Scholar
10.Furusyo, N, Hayashi, J, Ariyama, I, et al.Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection. Am J Gastroenterol 2000;95:490–496.CrossRefGoogle ScholarPubMed
11.Furusyo, N, Hayashi, J, Ariyama, I, et al.Lower hepatitis G virus infection prevalence compared to hepatitis B and C virus infection prevalences. Dig Dis Sci 2000;45:188–195.CrossRefGoogle Scholar
12.Furusyo, N, Hayashi, J, Kanamoto-Tanaka, Y, et al.Liver damage in hemodialysis patients with hepatitis C virus viremia: a prospective 10-year study. Dig Dis Sci 2000;45:2221–2228.Google Scholar
13.Yamaji, K, Hayashi, J, Kawakami, Y, et al.Long term survey of hepatitis C virus infection in hemodialysis units in Fukuoka, Japan. J Epidemiol 1996;6:166–171.Google Scholar
14.Choo, QL, Kuo, G, Werner, AJ, et al.Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359–362.Google Scholar
15.Okamoto, H, Sugiyama, Y, Okada, S, et al.Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673–679.Google Scholar
16.Hayashi, J, Yoshimura, E, Kishihara, Y, et al.Hepatitis C virus RNA levels determined by branched DNA probe assay correlated with levels assessed using competitive PCR. Am J Gastroenterol 1996;91:314–318.Google Scholar
17.Simmonds, P, Alberti, A, Alter, HJ, et al.A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994;19:1321–1324.Google Scholar
18.Okamoto, H, Kurai, K, Okada, S, et al.Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 1992;188:331–341.CrossRefGoogle ScholarPubMed
19.Viazov, S, Zibert, A, Ramakrishnan, K, et al.Typing of hepatitis C virus isolates by DNA enzyme immunoassay. J Virol Methods 1994;48:81–91.CrossRefGoogle ScholarPubMed
20.Di Bisceglie, AM. Hepatitis C. Lancet 1998;351:351–355.Google Scholar
21.Ross, RS, Viazov, S, Gross, T, et al.Transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients. N Engl J Med 2000;343:1851–1854.Google Scholar
22.Izopet, J, Pasquier, C, Sandres, K, et al.Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J Med Virol 1999;58:139–144.Google Scholar
23.Norder, H, Bergstrom, A, Uhnoo, I, et al.Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region. J Clin Microbiol 1998;36:3066–3069.Google Scholar
24.Bruguera, M, Saiz, JC, Franco, S, et al.Outbreak of nosocomial hepatitis C virus infection resolved by genetic analysis of HCV RNA. J Clin Microbiol 2002;40:4363–4366.Google Scholar
25.Kokubo, S, Horii, T, Yonekawa, O, et al.A phylogenetic-tree analysis elucidating nosocomial transmission of hepatitis C virus in a haemodialysis unit. J Viral Hepat 2002;9:450–454.Google Scholar
26.Tallis, GF, Ryan, GM, Lambert, SB, et al.Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoules. J Viral Hepat 2003;10:234–239.Google Scholar
27.Collier, AJ, Tang, S, Elliott, RM. Translation efficiencies of the 5' untranslated region from representatives of the six major genotypes of hepatitis C virus using a novel bicistronic reporter assay system. J Gen Virol 1998;79:2359–2366.Google Scholar
28.Soler, M, Pellerin, M, Malnou, CE, et al.Quasispecies heterogeneity and constraints on the evolution of the 5' noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy. Virology 2002;298:160–173.Google Scholar
29.Hayashi, J, Kishihara, Y, Yamaji, K, et al.Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology 1997;25:697–701.Google Scholar
30.Hayashi, J, Furusyo, N, Ariyama, I, et al.A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia. J Infect Dis 2000;181:1523–1527.Google Scholar
31.Farci, P, Shimoda, A, Coiana, A, et al.The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000;288:339–344.Google Scholar
32.Barril, G, Bartolome, J, Traver, JA, et al.Autoclaving eliminates hepatitis C virus from a hemodialysis monitor contaminated artificially. J Med Virol 2000;60:139–143.3.0.CO;2-5>CrossRefGoogle ScholarPubMed
33.Kaito, M, Watanabe, S, Tsukiyama-Kohara, K, et al.Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 1994;75:1755–1760.CrossRefGoogle ScholarPubMed
34.Centers for Disease Control and Prevention. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. JAMA 1988;260:462–465.Google Scholar
35.Izopet, J, Rostaing, L, Moussion, F, et al.High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy. J Infect Dis 1997;176:1614–1617.Google Scholar
36.Jaeckel, E, Cornberg, M, Wedemeyer, H, et al.Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001;345:1452–1457.Google Scholar